Bureaucrats, developer, Administrators
9,854
edits
User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
User:Jukeboksi/Wiki.study/Natural therapeutics (edit)
Revision as of 19:35, 11 October 2021
, 11 October 202128x http -> https corrections for links to ncbi.nlm.nih.gov (thanks Screming Frog SEO Spider)
(resolved bunch of HTTP (status code) 404, 303 and 301 situations in the outgoing links that https://www.screamingfrog.co.uk/seo-spider/ free version pointed out) |
(28x http -> https corrections for links to ncbi.nlm.nih.gov (thanks Screming Frog SEO Spider)) |
||
| Line 214: | Line 214: | ||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/ ''''''Anticancer mechanisms of cannabinoids'''''' at ncbi.nlm.nih.gov], a '''2016''' paper published in [[w:Current Oncology]] | * [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/ ''''''Anticancer mechanisms of cannabinoids'''''' at ncbi.nlm.nih.gov], a '''2016''' paper published in [[w:Current Oncology]] | ||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/ ''''''Integrating cannabis into clinical cancer care'''''' at ncbi.nlm.nih.gov], a '''2016''' study published in the journal [[w:Current Oncology]] | * [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/ ''''''Integrating cannabis into clinical cancer care'''''' at ncbi.nlm.nih.gov], a '''2016''' study published in the journal [[w:Current Oncology]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/20925645 ''''''Cannabis-derived substances in cancer therapy--an emerging anti-inflammatory role for the cannabinoids'''''' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2010''' '''review''', published in Current Clinical Pharmacology | ||
=== Links about cannabis and cancer in general === | === Links about cannabis and cancer in general === | ||
| Line 286: | Line 286: | ||
* [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors' at FrontiersIn.org], a '''2018''' '''perspective article''' published in Frontiers in Integrative Neuroscience by [[w:Frontiers Media]] | * [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors' at FrontiersIn.org], a '''2018''' '''perspective article''' published in Frontiers in Integrative Neuroscience by [[w:Frontiers Media]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2010''' '''comparative study''', published in [[w:Neurochemistry International]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/20090845 'The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2010''' study published in [[w:PLOS One]] on [[w:astrocytomas]] and cannabis receptors | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/17675107 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2009''' '''clinical trial''', published in [[w:Neuropharmacology (journal)]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/19480992 'Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2009''' study, published in [[w:Brain Research Bulletin]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/19229996 'Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2009''' study, published in [[w:Glia (journal)]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/19425170 'Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2009''' study, published in [[w:Journal of Clinical Investigation]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/18088200 'Cannabinoids as potential new therapy for the treatment of gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2008''' '''review''', published in ''Expert review on neurotherapies'' | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/18615640 'High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2008''' study published in [[w:Journal of Neuroscience Research]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/18339876 'Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2008''' study, published in [[w:Cancer Research (journal)]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/17952650 'Cannabinoids and gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2007''' '''review''', published in [[w:Molecular Neurobiology (journal)]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/17202146 'Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2007''' study, published in [[w:Journal of Biological Chemistry]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/16893424 'Cannabinoid receptors in human astroglial tumors' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2006''' study published in [[w:Journal of Neurochemistry]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/16909207 'The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2006''' study published in [[w:Cellular and Molecular Life Sciences]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089 'Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, '''2005''' study, published in [[w:British Journal of Pharmacology]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/15453094 'Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2004''' study, published in [[w:Journal of Neuropathology & Experimental Neurology]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/15313899 'Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2004''' study, published in [[w:Cancer Research (journal)]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/15275820 'Hypothesis: cannabinoid therapy for the treatment of gliomas?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2004''' '''review''', published in [[w:Neuropharmacology (journal)]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/14617682 'Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2004''' study, published in [[w:Journal of Pharmacology and Experimental Therapeutics]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/15361550 'Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2004''' study, published in [[w:Molecular Pharmacology]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/11479216 'Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2001''' study published in [[w:Cancer Research (journal)]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/9771884 'Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''1998''' study, published in [[w:FEBS Letters]] | ||
''' Links about brain cancer and cannabis''' | ''' Links about brain cancer and cannabis''' | ||
| Line 445: | Line 445: | ||
[[w:Hodgkin's lymphoma|Hodgkin's lymphoma]] is a type of [[w:lymphoma|lymphoma]] in which [[w:cancer|cancer]] originates from a specific type of [[w:white blood cell|white blood cell]]s called [[w:lymphocyte|lymphocyte]]s. (Wikipedia) | [[w:Hodgkin's lymphoma|Hodgkin's lymphoma]] is a type of [[w:lymphoma|lymphoma]] in which [[w:cancer|cancer]] originates from a specific type of [[w:white blood cell|white blood cell]]s called [[w:lymphocyte|lymphocyte]]s. (Wikipedia) | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/19609004 'Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism ' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2009''' study, published in [[w:Molecular Cancer Research]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/18546271 'Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation ' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2008''' study, published in [[w:International Journal of Cancer]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/16936228 'Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2006''' study, published in [[w:Molecular Pharmacology]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/16337199 'Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma ' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2005''' comparative study, published in [[w:FEBS Letters]] | ||
== Lymphoma and cannabis == | == Lymphoma and cannabis == | ||
| Line 504: | Line 504: | ||
* [https://www.nature.com/articles/s41388-018-0390-1 ''''''GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine''''''], a '''2018''' study published in [[w:Oncogene (journal)|Oncogene]]. Forbes.com news item on the study [https://www.forbes.com/sites/daviddisalvo/2018/07/31/study-cbd-from-marijuana-plus-chemotherapy-triples-cancer-survival-rates-in-mice/ 'Study: CBD From Marijuana Plus Chemotherapy Tripled Cancer Survival Rates In Mice'] | * [https://www.nature.com/articles/s41388-018-0390-1 ''''''GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine''''''], a '''2018''' study published in [[w:Oncogene (journal)|Oncogene]]. Forbes.com news item on the study [https://www.forbes.com/sites/daviddisalvo/2018/07/31/study-cbd-from-marijuana-plus-chemotherapy-triples-cancer-survival-rates-in-mice/ 'Study: CBD From Marijuana Plus Chemotherapy Tripled Cancer Survival Rates In Mice'] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/16818650 ''''''Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes'''''' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2006''' study published in [[w:Cancer Research (journal)]] | ||
* [ | * [https://www.ncbi.nlm.nih.gov/pubmed/16500647 ''''''Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism'''''' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2006''' study, published in [[w:FEBS Letters]] | ||
=== Pancreatic cancer and ginger === | === Pancreatic cancer and ginger === | ||
| Line 831: | Line 831: | ||
== Strokes and cannabis == | == Strokes and cannabis == | ||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348386/ 'Cannabinoids in experimental stroke: a systematic review and meta-analysis'], a 2014 meta-review published in | * [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348386/ 'Cannabinoids in experimental stroke: a systematic review and meta-analysis'], a 2014 meta-review published in the [[w:Journal of Cerebral Blood Flow & Metabolism]]. [https://www.medicaljane.com/2014/12/31/marijuana-may-reduce-brain-damage-caused-by-strokes/ 'Study: Cannabis May Help Reduce Brain Damage Caused By Ischemic Strokes'], an MedicalJane.com article on the study | ||
---- | ---- | ||